RTS
ACAD icon

Round Table Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Round Table Services’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-12,247
Closed -$505K – 97
2020
Q3 		$505K Buy
+12,247
New +$529K 0.22% 48

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Round Table Services's ACAD Position: Q4 2020 in Review

Round Table Services sold out of Acadia Pharmaceuticals (ACAD) in Q4 2020, closing a stake of 12,247 shares — an estimated $505K sold.

Round Table Services first reported a position in ACAD in Q3 2020 and held it in 1 quarter. The position peaked at $505K in Q3 2020. 308 funds tracked by Wall St. Rank hold ACAD as of Q4 2020.

  • Round Table Services reported no remaining Acadia Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Round Table Services sold 12,247 Acadia Pharmaceuticals shares in Q4 2020, an estimated $505K.
  • Round Table Services first reported a position in Acadia Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Round Table Services's Acadia Pharmaceuticals position peaked at $505K in Q3 2020.
  • 308 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2020.

Based on Round Table Services's 13F filing for Q4 2020, filed 11 Feb 2021.